NA
AMED

Neuburgh Advisers’s Amedisys AMED Stock Holding History

Neuburgh Advisers’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$382K Hold
2,912
– – 0.01% 525
2019
Q2 		$354K Hold
2,912
– – 0.01% 552
2019
Q1 		$359K Hold
2,912
– – 0.01% 532
2018
Q4 		$341K Hold
2,912
– – 0.01% 498
2018
Q3 		$364K Buy
2,912
+752
+35% +$83K 0.01% 571
2018
Q2 		$185K Hold
2,160
– – 0.01% 670
2018
Q1 		$130K Hold
2,160
– – ﹤0.01% 743
2017
Q4 		$114K Buy
2,160
+176
+9% +$9.28K ﹤0.01% 769
2017
Q3 		$111K Buy
1,984
+256
+15% +$13.5K ﹤0.01% 739
2017
Q2 		$109K Buy
1,728
+784
+83% +$45.7K ﹤0.01% 711
2017
Q1 		$48K Sell
944
-112
-11% -$5.34K ﹤0.01% 761
2016
Q4 		$45K Buy
+1,056
New +$44.9K ﹤0.01% 757

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Neuburgh Advisers's AMED Position: Q3 2019 in Review

Neuburgh Advisers held its Amedisys (AMED) position steady in Q3 2019 at 2,912 shares worth $382K. The position accounts for 0.01% of the portfolio, ranked #525.

Neuburgh Advisers first reported a position in AMED in Q4 2016 and has held it in 12 quarters since. 283 funds tracked by Wall St. Rank hold AMED as of Q3 2019.

  • Neuburgh Advisers held 2,912 shares of Amedisys worth $382K as of Q3 2019.
  • Neuburgh Advisers left its Amedisys share count unchanged in Q3 2019.
  • Amedisys made up 0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #525 holding.
  • Neuburgh Advisers first reported a position in Amedisys in Q4 2016 and has held it in 12 quarters since.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.